Soleus Capital Management, L.P.

Soleus Capital Management, L.P. reported 97 holdings worth US$2.81B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Soleus Capital Management, L.P. reported 97 holdings worth US$2.81B as of Sep 30, 2026. Largest: Krystal Biotech, Inc., Insulet Corporation and TG Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
97
Value as reported
US$2.81B

The filing in full

CompanySharesValue as reported% of portfolio
Krystal Biotech, Inc.1.14MUS$379M13.5%
Insulet Corporation1.73MUS$225M8.0%
TG Therapeutics, Inc.2.56MUS$143M5.1%
United Therapeutics Corporation259KUS$140M5.0%
Celcuity Inc.1.68MUS$134M4.8%
Rigel Pharmaceuticals, Inc.1.84MUS$88.8M3.2%
Inspire Medical Systems, Inc.1.21MUS$83.7M3.0%
Erasca, Inc.5.11MUS$74.9M2.7%
Beta Bionics, Inc.3.74MUS$71.1M2.5%
ANI Pharmaceuticals, Inc.976KUS$70.9M2.5%
Vericel Corporation1.55MUS$62.4M2.2%
Geron Corporation46.8MUS$57.5M2.0%
Parabilis Medicines, Inc.1.68MUS$54.4M1.9%
argenx SE49,350US$47.3M1.7%
Axogen, Inc.1.08MUS$45.3M1.6%
NeuroPace, Inc.3.22MUS$44.3M1.6%
Evolus, Inc. Common Stock5.09MUS$40.7M1.4%
Zai Lab Ltd.1.54MUS$40.6M1.4%
Progyny, Inc.1.58MUS$39.9M1.4%
Trevi Therapeutics, Inc.2.73MUS$39.1M1.4%
Nuvectis Pharma, Inc.1.71MUS$36.1M1.3%
Edap Tms SA7.31MUS$32.7M1.2%
Avalyn Pharma Inc.1.02MUS$29M1.0%
Kodiak Sciences Inc287KUS$27.2M0.97%
Silence Therapeutics PLC2.39MUS$26.1M0.93%
Inhibikase Therapeutics, Inc.11.2MUS$23.1M0.82%
Arcus Biosciences, Inc.862KUS$22.3M0.79%
Legend Biotech Corp.1.09MUS$21.6M0.77%
Nurix Therapeutics, Inc.892KUS$21.2M0.75%
Inhibrx Biosciences, Inc.210KUS$21M0.75%
Adlai Nortye Group Ltd.1.27MUS$20.4M0.72%
Palisade Bio, Inc.15MUS$20.2M0.72%
Tango Therapeutics, Inc.802KUS$20M0.71%
Biodesix, Inc.668KUS$19.9M0.71%
Insmed Incorporated147KUS$16.8M0.60%
Praxis Precision Medicines, Inc.56,515US$16.5M0.59%
Jade Biosciences, Inc.1.17MUS$16.5M0.58%
CONMED Corporation347KUS$16.1M0.57%
Eton Pharmaceuticals, Inc.308KUS$15.9M0.56%
OrthoPediatrics Corp.710KUS$15.8M0.56%
Organogenesis Holdings Inc.11.3MUS$15.5M0.55%
GRAIL, Inc.109KUS$15.2M0.54%
MBX Biosciences, Inc.259KUS$15.2M0.54%
Edgewise Therapeutics, Inc.330KUS$13.4M0.48%
Amneal Pharmaceuticals, Inc.658KUS$13.3M0.47%
Prelude Therapeutics Incorporated3.38MUS$13.2M0.47%
Septerna, Inc.330KUS$12.9M0.46%
Syndax Pharmaceuticals, Inc.616KUS$11.6M0.41%
Sanofi SA275KUS$11.3M0.40%
C4 Therapeutics, Inc.3.36MUS$11.2M0.40%
PROCEPT BioRobotics Corporation600KUS$10.9M0.39%
Tyra Biosciences, Inc.445KUS$9.73M0.35%
Twist Bioscience Corporation47,532US$9.19M0.33%
Iovance Biotherapeutics, Inc.552KUS$8.18M0.29%
Xenon Pharmaceuticals Inc.205KUS$7.62M0.27%
Revolution Medicines, Inc.36,249US$7.44M0.26%
BioMarin Pharmaceutical Inc.121KUS$7.27M0.26%
Capricor Therapeutics, Inc.699KUS$6.62M0.24%
Invivyd, Inc.7.52MUS$6.55M0.23%
Pulmonx Corporation3.09MUS$5.9M0.21%
Avalo Therapeutics, Inc.384KUS$5.88M0.21%
Castle Biosciences, Inc.141KUS$5.01M0.18%
First Tracks Biotherapeutics, Inc.141KUS$4.98M0.18%
Glaukos Corporation25,552US$4.2M0.15%
TCGX Acquisition Corp.225KUS$2.81M0.10%
Electra Therapeutics, Inc.250KUS$2.81M0.10%
Satellos Bioscience Inc330KUS$2.81M0.10%
Solid Biosciences Inc.368KUS$2.66M0.09%
SAB Biotherapeutics, Inc.672KUS$2.13M0.08%
Context Therapeutics Inc.7.06MUS$2.12M0.08%
Zentalis Pharmaceuticals, Inc.706KUS$1.96M0.07%
Tandem Diabetes Care, Inc.100KUS$1.63M0.06%
Waystar Holding Corp.50,000US$1.27M0.05%
MannKind Corporation300KUS$1.17M0.04%
Cerus Corporation450KUS$1.07M0.04%
Aprea Therapeutics, Inc.1MUS$750K0.03%
InspireMD Inc.1.05MUS$698K0.02%
NextCure, Inc.90,000US$451K0.02%
Indivior Pharmaceuticals, Inc.10,000US$359K0.01%
Processa Pharmaceuticals, Inc.161KUS$264K<0.01%
Belite Bio, Inc.1,524US$259K<0.01%
BioNTech SE2,500US$246K<0.01%
UnitedHealth Group Incorporated660US$242K<0.01%
Vir Biotechnology, Inc.20,971US$234K<0.01%
QuidelOrtho Corporation20,000US$211K<0.01%
Attovia Therapeutics, Inc.10,000US$171K<0.01%
Equillium, Inc.90,000US$146K<0.01%
RxSight, Inc.20,000US$98,000<0.01%
CG Oncology, Inc.0US$00.00%
Corcept Therapeutics Incorporated0US$00.00%
Cullinan Therapeutics, Inc.0US$00.00%
Enliven Therapeutics, Inc.0US$00.00%
GeneDx Holdings Corp.0US$00.00%
Globus Medical, Inc.0US$00.00%
Immunic, Inc.0US$00.00%
Immunovant, Inc.0US$00.00%
Karyopharm Therapeutics Inc.0US$00.00%
Larimar Therapeutics, Inc.0US$00.00%
Merck & Company, Inc.0US$00.00%
Mirum Pharmaceuticals, Inc.0US$00.00%

Every holding of Soleus Capital Management, L.P.

Source

Download original · View original at SEC

Related